IP Library Granted Patent US 8,466,129
Granted Patent B2
US 8,466,129 · App. 12/605,783 · Granted Jun 18, 2013

Method of preventing and treating airway remodeling and pulmonary inflammation using A

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,466,129
App. No.
12/605,783
Granted
Jun 18, 2013
Kind
B2
Abstract

The present invention relates to methods of preventing airway remodeling using A 2B adenosine receptor antagonists. This invention finds utility in the treatment and prevention of asthma, COPD, pulmonary fibrosis, emphysema, and other pulmonary diseases. The invention also relates to pharmaceutical compositions for use in the method.

Claims (7)

1. A method for the treatment of chronic obstructive pulmonary disease (COPD), said method comprising administering to a mammal in need thereof a pharmaceutical composition comprising a therapeutically effective amount of 3-ethyl-1-propyl-8- {1- [(3-trifluoromethylphenyl)methyl]pyrazol-4-yl}-1,3,7-trihydropurine-2,6-dione, having the chemical structure

wherein an A 3 adenosine receptor antagonist is not administered to said mammal.

2. The method of claim 1 , wherein the administration is oral.

3. The method of claim 1 , wherein the administration is intravenous.

4. The method of claim 1 , wherein the administration is intramuscular.

5. The method of claim 1 , wherein the administration is intraperitoneal.

6. The method of claim 1 , wherein the administration is by inhalation.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2011
From: GILEAD PALO ALTO, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 027077/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2011
From: GILEAD PALO ALTO, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 025888/0250 →
MERGER Recorded Feb 24, 2011
From: CV THERAPEUTICS, INC.; APEX MERGER SUB, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 025860/0769 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2011
From: ZENG, DEWAN; BELARDINELLI, LUIZ; BLACKBURN, MICHAEL R.
To: CV THERAPEUTICS, INC.
Reel/Frame 025844/0621 →